Authors
Ivo Carre, PhD, is a senior business analyst at Lifescience Dynamics.
Oscar B. Lahoud, MD, is clinical associate professor at NYU School of Medicine; section chief, Hematology, NYU Langone Health in Brooklyn; and director for strategy and network operations, Hematology/Oncology, the Perlmutter Cancer Center.
Neal Bhatia, MD
Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, CA
Sam Peasah, PhD, MBA, RPh, director of high-value health care, University of Pittsburgh Medical Center
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
3
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
4
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
5
